Moderna
Trade Moderna 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.
MRNA Key Statistics
Stock Snapshot
With a market cap of 17.7B, Moderna(MRNA) trades at $45.35. The stock has a price-to-earnings ratio of -5.62.
On 2026-01-29, Moderna(MRNA) stock traded between a low of $45.32 and a high of $45.69. Shares are currently priced at $45.35, which is +0.1% above the low and -0.7% below the high.
Moderna(MRNA) shares are trading with a volume of 43.36K, against a daily average of 16.82M.
In the last year, Moderna(MRNA) shares hit a 52-week high of $55.20 and a 52-week low of $22.28.
In the last year, Moderna(MRNA) shares hit a 52-week high of $55.20 and a 52-week low of $22.28.
MRNA News
Moderna (NasdaqGS:MRNA) plans to stop funding new Phase III vaccine trials in the U.S., citing a more hostile vaccine climate. The company aims to secure exter...
Barclays analyst Eliana Merle assumed coverage of Moderna (MRNA) with an Equal Weight rating and $25 price target Barclays initiated coverage of 12 biotech stoc...
Moderna (MRNA) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium Study Overview This Phase 3 study, officially titled “A Ph...
Analyst ratings
74%
of 27 ratingsMore MRNA News
Moderna ( (MRNA) ) has risen by 16.45%. Read on to learn why. Claim 50% Off TipRanks Premium Unlock hedge fund-level data and powerful investing tools for smart...
Moderna (MRNA) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium Unlock hedge fund-level data and powerful investing tools for...
Moderna (MRNA) CEO Stéphane Bancel said on Thursday that his company will not fund further late-stage development of vaccines as the U.S. government pushes back...
Shares of drug maker Moderna (MRNA) are up 10% on Jan. 22 after the company reported positive trial results for its newest cancer drug. Claim 50% Off TipRanks...
Moderna extends rally on positive cancer vaccine results Moderna has more than doubled since it announced on Tuesday that its cancer vaccine reduced the risk o...
Moderna’s (MRNA) chief executive officer said the company doesn’t plan to invest in new late-stage vaccine trials because of growing opposition to immunizations...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.